Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study

Clinical trial NCT05361720 · RECRUITING

Trial details

NCT number: NCT05361720
Sponsor: Vanderbilt-Ingram Cancer Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Clear Cell Renal Cell Carcinoma Metastatic Clear Cell Renal Cell Carcinoma Stage III Renal Cell Cancer AJCC v8 Stage IV Renal Cell Cancer AJCC v8

Start date: 2022-12-06
Primary completion: 2026-10-01
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.